JPRN-UMIN000022695已完成未知
3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation - MODEL U-SES
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- Patients previously experienced stent thrombosis - Patients who are unable to follow up - Patients who are enrolled or planned to participate in another clinical trials of antiplatelet therapy.
研究者
相似试验
Unknown
不适用
3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent ImplantationCoronary Artery DiseaseNCT02837003Teikyo University1,500
尚未招募
不适用
One-Month Dual Antiplatelet Therapy followed by P2Y12 Inhibitor Monotherapy After Biofreedom Ultra® Stent Implantation in Patients with Acute Coronary Syndrome: DAPT-FREE TRIAKCT0006530Chonnam National University Hospital1
尚未招募
不适用
Effect of potent P2Y12 inhibitor monotherapy after double antiplatelet therapy for 1 month after PCI in ACS patientsDiseases of the circulatory systemKCT0006861Chonnam National University Hospital2,000
进行中（未招募）
1 期
Early reduction of antiplatelet therapy in patients with Acute Coronary Syndrome treated with stent implantation and at high risk of bleeding.MedDRA version: 20.0Level: PTClassification code: 10051592Term: Acute coronary syndrome Class: 100000004849Acute coronary syndromeCTIS2023-509868-20-00Azienda Ospedaliera Universitaria Gaetano Martino Messina200
招募中
1 期
Early reduction of antiplatelet therapy in patients with Acute Coronary Syndrome treated with stent implantation and at high risk of bleedingEUCTR2023-000029-10-ITAzienda Ospedaliera Universitaria Gaetano Martino Messina200